Sinopharm\'s agreement: Announcement of the resolution of the 3rd Interim Meeting of the 10th Board of Directors in 2024
Sinopharm is consistent: report for the third quarter of 2024
Sinopharm is consistent: quick performance report for the first three quarters of 2024
Sinopharm agrees: Announcement of the resolution of the 2nd Interim Meeting of the 10th Board of Directors in 2024
Sinopharm Unanimity: Announcement on Senior Executives Retirement
Sinopharm agreement: announcement of the resolution of the first interim meeting of the 10th board of directors in 2024
Sinopharm\'s agreement: announcement on changes to accounting firms
Sinopharm Unanimity: Announcement on Senior Executives Retirement
Sinopharm Consistency: 000028 Sinopharm Investor Relations Management Information 20240903
Sinopharm is consistent: summary of the 2024 semi-annual report
Sinopharm\'s agreement: semi-annual report board resolution announcement
Sinopharm is consistent: 2024 semi-annual financial report
Sinopharm Conforms: Report on Continued Risk Assessment of Sinopharm Group Finance Co., Ltd.
Sinopharm is consistent: 2024 semi-annual report
Sinopharm Consistent: Semi-Annual Financial Report
Sinopharm Consistent: Semi-Annual Report Supervisory Board Resolutions Announcement
Sinopharm is consistent: a summary table of non-operating capital usage and other related capital transactions for the half year
China National Accord Medicines Corporation: 2024 Half-Year Performance Bulletin
China National Accord Medicines Corporation: Announcement of Resolutions of the First Meeting of the Tenth Board of Directors.
China National Accord Medicines Corporation: Board of directors' compensation and assessment committee work system.
No Data
No Data